These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3528401)

  • 1. Elevated ras oncogene expression correlates with lymph node metastases in breast cancer patients.
    Lundy J; Grimson R; Mishriki Y; Chao S; Oravez S; Fromowitz F; Viola MV
    J Clin Oncol; 1986 Sep; 4(9):1321-5. PubMed ID: 3528401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ras, c-myc and c-erbB-2 oncoproteins in human breast cancer.
    Spandidos DA; Yiagnisis M; Papadimitriou K; Field JK
    Anticancer Res; 1989; 9(5):1385-93. PubMed ID: 2574023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence of breast cancer antigens in uninvolved axillary lymph nodes.
    Hendler FJ; House D
    Cancer Res; 1985 Jul; 45(7):3364-73. PubMed ID: 4005859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer.
    van de Vijver MJ; Peterse JL; Mooi WJ; Wisman P; Lomans J; Dalesio O; Nusse R
    N Engl J Med; 1988 Nov; 319(19):1239-45. PubMed ID: 2903446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of breast cancer axillary lymph node metastases with stem cell mutations.
    Donovan CA; Pommier RF; Schillace R; O'Neill S; Muller P; Alabran JL; Hansen JE; Murphy JA; Naik AM; Vetto JT; Pommier SJ
    JAMA Surg; 2013 Sep; 148(9):873-8. PubMed ID: 23884447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of c-erbB-2 and estrogen receptor status in human breast cancer.
    McCann AH; Dervan PA; O'Regan M; Codd MB; Gullick WJ; Tobin BM; Carney DN
    Cancer Res; 1991 Jun; 51(12):3296-303. PubMed ID: 1674898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis.
    D'Andrea MR; Limiti MR; Bari M; Zambenedetti P; Montagutti A; Ricci F; Pappagallo GL; Sartori D; Vinante O; Mingazzini PL
    Breast Cancer Res Treat; 2007 Mar; 101(3):279-84. PubMed ID: 16835704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Staging of women with breast cancer after introduction of sentinel node guided axillary dissection.
    Tvedskov TF
    Dan Med J; 2012 Jul; 59(7):B4475. PubMed ID: 22759850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete axillary lymph node dissection for stage I-II carcinoma of the breast.
    Danforth DN; Findlay PA; McDonald HD; Lippman ME; Reichert CM; d'Angelo T; Gorrell CR; Gerber NL; Lichter AS; Rosenberg SA
    J Clin Oncol; 1986 May; 4(5):655-62. PubMed ID: 3701387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitation of Harvey ras p21 enhanced expression in human breast and colon carcinomas.
    Hand PH; Vilasi V; Thor A; Ohuchi N; Schlom J
    J Natl Cancer Inst; 1987 Jul; 79(1):59-65. PubMed ID: 3298786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A significant correlation between nuclear CXCR4 expression and axillary lymph node metastasis in hormonal receptor negative breast cancer.
    Woo SU; Bae JW; Kim CH; Lee JB; Koo BW
    Ann Surg Oncol; 2008 Jan; 15(1):281-5. PubMed ID: 17763975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunolymphscintigraphy of axillary lymph node metastases in breast cancer patients using monoclonal antibodies: first clinical findings.
    Mandeville R; Pateisky N; Philipp K; Kubista E; Dumas F; Grouix B
    Anticancer Res; 1986; 6(6):1257-63. PubMed ID: 3813482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoperoxidase staining in the detection of lymph node metastases in stage I breast cancer.
    Raymond WA; Leong AS
    Pathology; 1989 Jan; 21(1):11-5. PubMed ID: 2474791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ras p21 expression in the progression of breast cancer.
    Fromowitz FB; Viola MV; Chao S; Oravez S; Mishriki Y; Finkel G; Grimson R; Lundy J
    Hum Pathol; 1987 Dec; 18(12):1268-75. PubMed ID: 3315956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of ras oncogene p21 in prostate cancer.
    Viola MV; Fromowitz F; Oravez S; Deb S; Finkel G; Lundy J; Hand P; Thor A; Schlom J
    N Engl J Med; 1986 Jan; 314(3):133-7. PubMed ID: 2417118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients.
    Pendas S; Dauway E; Cox CE; Giuliano R; Ku NN; Schreiber RH; Reintgen DS
    Am Surg; 1999 Jun; 65(6):500-5; discussion 505-6. PubMed ID: 10366202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast-Enhanced Ultrasound Biopsy of Sentinel Lymph Nodes in Patients with Breast Cancer: Implications for Axillary Metastases and Conservation.
    Cox K; Weeks J; Mills P; Chalmers R; Devalia H; Fish D; Sever A
    Ann Surg Oncol; 2016 Jan; 23(1):58-64. PubMed ID: 25990967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphologic assessment of reactivity to monoclonal antibodies generated against breast cancer cells in mammary tissues removed for clinical dysplasia or cancer.
    Nuti M; Castagna M; Squartini F
    Appl Pathol; 1984; 2(3):117-27. PubMed ID: 6085790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical study of the ras oncogene expression in human breast lesions.
    Agnantis NJ; Petraki C; Markoulatos P; Spandidos DA
    Anticancer Res; 1986; 6(5):1157-60. PubMed ID: 3541779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.